The agents analyse referral networks, procedure volumes, and payer mix to prioritise physicians and facilities most likely to convert.US-based healthtech startup MedScout has raised $10 million in a growth round led by Fulcrum Equity Partners, with participation from existing investors Live Oak Venture Partners and Stage 2 Capital.
The fresh funding will be used to expand the firm’s artificial intelligence capabilities and support its enterprise customers.
“MedScout bridges that gap by translating commercial priorities into clear, territory-specific actions. Sales reps know which providers to prioritise and how to build and expand those relationships,” said Skylar Talley, co-founder and CEO of MedScout.
It currently builds commercial software for medical technology companies, helping translate corporate strategy into territory-level sales execution. Alongside the funding, the company launched AI agents designed to generate ready-to-deploy territory plans for field representatives.
The agents analyse referral networks, procedure volumes, and payer mix to prioritise physicians and facilities most likely to convert.
“What they’ve built combines commercial expertise and AI to solve that problem in a highly actionable way that’s unique to each customer. This is the future of how companies put AI to work, and it’s why we’re doubling down on our investment in MedScout,” said Philip Lewis, Partner at Fulcrum Equity Partners.
The company made its AI agents available to customers in late 2025. In January, it added that customers deployed 81 per cent more unique AI agents month-on-month, showcasing broader adoption within sales teams.
MedScout said enterprise revenue has grown threefold since its Series A in July 2024, while monthly active sales representatives have increased 135 per cent as customers expand usage.
Leave a Reply